Company Overview and News

36
Run Over By A Benz

2018-06-22 seekingalpha
Big news for the trade war risk narrative: Daimler just became the first major company to cut its outlook citing trade tensions.
WFC WFCNP WFC.WS FXI WFC.PRL SCGLY WFC.PRJ DDAIF WFC.PRT WFC.PRR WFC.PRQ SCGLF WFC.PRP WFC.PRO WFC.PRN WFC.PRY GLE WFC.PRX WFC.PRW VLKAY WFC.PRV

3
Trade war piles pain on China-exporter emerging markets

2018-06-21 theedgemarkets
LAGOS (June 21): Just when it looked like things couldn’t get much worse for emerging markets, along comes a trade war. And it’s hitting emerging-market commodity suppliers and exporters to China especially hard.
SCGLF SCGLY GLE

16
Malakoff indirect unit draws down RM1.5bil

2018-06-21 thestar.com.my
Malakoff, which is an independent power producer with the largest capacity in Southeast Asia, announced to Bursa Malaysia its indirect unit Win Macarthur Finco Pty Ltd (WMFPL) had drawn down the amount for the existing term loan.
BNPZY SCGLF BNPQY SCGLY GLE BNPQF BSMAF O39 1818

3
Malaysian palm oil price charts 3rd day of losses, still trading at 2-year lows

2018-06-20 thestar.com.my
The benchmark palm oil contract for September delivery on the Bursa Malaysia Derivatives Exchange edged down 0.04 percent to 2,262 ringgit ($564.94) per tonne at the end of the trading day, near the previous session's two-year low. Palm fell as much as 3 percent on Tuesday to 2,238 ringgit, and is down 6.9 percent so far for the month. Trading volumes stood at 65,817 lots of 25 tonnes each at the close of trade
SCGLF SCGLY GLE

37
Deutsche Bank to pay US$205 million to settle NY currency rigging charges

2018-06-20 channelnewsasia
Deutsche Bank AG has agreed to pay a fine of US$205 million for violations of New York's banking laws, the state's department of financial Services said on Wednesday.
STAN DB BNPQY MS.PRE SCGLY MS.PRF MS.PRG BNPQF MS.PRA BNPZY SCGLF MS.PRI STAB MS.PRK 580001 STAC SCBFF STAN 2888 GLE MS

37
Deutsche Bank to pay $205 mln to settle NY currency rigging charges

2018-06-20 reuters
June 20 (Reuters) - Deutsche Bank AG has agreed to pay a fine of $205 million for violations of New York’s banking laws, the state’s department of financial Services said on Wednesday.
STAN DB BNPQY MS.PRE SCGLY MS.PRF MS.PRG BNPQF MS.PRA BNPZY SCGLF MS.PRI STAB MS.PRK 580001 STAC SCBFF STAN 2888 GLE MS

37
Deutsche Bank to pay $205 million to settle NY currency rigging charges

2018-06-20 reuters
(Reuters) - Deutsche Bank AG (DBKGn.DE) has agreed to pay a fine of $205 million for violations of New York’s banking laws, the state’s department of financial Services said on Wednesday.
STAN DB BNPQY MS.PRE SCGLY MS.PRF MS.PRG BNPQF MS.PRA BNPZY SCGLF MS.PRI STAB MS.PRK 580001 STAC SCBFF STAN 2888 GLE MS

23
Leagold: A Brand New Mid-Tier Gold Miner With A More Than 100% Near-Term Upside Potential

2018-06-20 seekingalpha
Leagold should produce 420,000-475,000 toz gold at an AISC around $930/toz in 2018, however, its production should grow to the 700,000 toz level by 2020.
OCANF SCGLF AUY YRI EDVVF EDVMF SCGLY EVR GLE GG HTXFF EDV

3
Malaysian palm oil price slumps to 2-year low tracking weaker soyoil

2018-06-19 thestar.com.my
The benchmark palm oil contract for September delivery on the Bursa Malaysia Derivatives Exchange was down 1.9 percent at 2,263 ringgit ($565.47) per tonne at the close of trade, its sharpest daily drop since early March. It earlier fell to its lowest since July 15, 2016 at 2,238 ringgit
SCGLF SCGLY GLE

3
Palm slumps to near 2-year low tracking soyoil

2018-06-19 theedgemarkets
KUALA LUMPUR (June 19): Malaysian palm oil futures slumped more than 2% on Tuesday to their lowest in nearly two years, tracking weakness in related edible oils.
SCGLF SCGLY GLE

3
Oil rises ahead of Opec meet, China tariffs loom over US prices

2018-06-18 malaymail
NEW YORK, June 19 — Oil prices rose on yesterday in volatile trade as market participants lowered their expectations for how much Opec might increase production and investors assessed the impact of a trade dispute between the United States and China.
SCGLF SCGLY GLE

3
Malaysian palm oil price slips over 1% on weaker demand, crude oil

2018-06-18 thestar.com.my
The benchmark palm oil contract for September delivery on the Bursa Malaysia Derivatives Exchange was down 1.2 percent at 2,307 ringgit ($577.33) per tonne at the end of the trading day. It had gained 0.7 percent in the previous session following eight consecutive days of falls. Trading volumes stood at 62,352 lots of 25 tonnes each on Monday evening.
SCGLF SCGLY GLE

3
OPEC Aims for Modest Output Hike to Overcome Iran's Dissent - Bloomberg

2018-06-18 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
SCGLF DNBHF SCGLY GLE DNHBY

3
OPEC Aims for Modest Output Hike to Overcome Iran's Dissent

2018-06-18 rigzone
(Bloomberg) -- OPEC is discussing a relatively modest production increase before its meeting in Vienna this week, an attempt to bridge the gap between Russia’s push for a big rise and Iran’s insistence that no change is needed.
SCGLF DNBHF SCGLY GLE DNHBY

3
Opec aims for modest output hike to overcome Iran’s dissent

2018-06-18 malaymail
DUBAI, June 18 — Opec is discussing a relatively modest production increase before its meeting in Vienna this week, an attempt to bridge the gap between Russia’s push for a big rise and Iran’s insistence that no change is needed.
SCGLF DNBHF SCGLY GLE DNHBY

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

CUSIP: 83364L109